×
About 875 results

ALLMedicine™ Acute Intermittent Porphyria Center

Research & Reviews  361 results

Health impact of acute intermittent porphyria in latent and non-recurrent attacks patie...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913433
Orphanet Journal of Rare Diseases; Buendía-Martínez J, Barreda-Sánchez M et. al.

Feb 28th, 2021 - Acute intermittent porphyria (AIP) is a genetic disease characterized by acute neurovisceral attacks. Long-term clinical conditions, chronic symptoms and impaired health related quality of life (HRQoL) have been reported during non-attack periods ...

Severe neuropathic attack in a woman with acute intermittent porphyria: a case report.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809922
The Journal of International Medical Research; Huang S, Li R et. al.

Jan 12th, 2021 - Acute intermittent porphyria (AIP) is a rare autosomal dominant metabolic disease with a broad spectrum of clinical manifestations, and can be easily confused with other diseases. Many patients with porphyria may have symptoms of peripheral nerve ...

Expanding Experience With Liver Transplantation in Acute Intermittent Porphyria.
https://doi.org/10.1002/lt.25979
Liver Transplantation : Official Publication of the Ameri... Moghe A, Anderson KE

Dec 28th, 2020 - Expanding Experience With Liver Transplantation in Acute Intermittent Porphyria.|2020|Moghe A,Anderson KE,|

Updates on the diagnosis and management of the most common hereditary porphyrias: AIP a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727547
Hematology. American Society of Hematology. Education Pro... Linenberger M, Fertrin KY

Dec 4th, 2020 - The porphyrias are a family of metabolic disorders caused by defects in the activity of one of the enzymes in the heme biosynthetic pathway. Acute intermittent porphyria (AIP), caused by autosomal dominant mutations in the gene encoding hydroxymet...

Liver Transplantation for Acute Intermittent Porphyria.
https://doi.org/10.1002/lt.25959
Liver Transplantation : Official Publication of the Ameri... Lissing M, Nowak G et. al.

Dec 1st, 2020 - Recurrent attacks of acute intermittent porphyria (AIP) result in poor quality of life and significant risks of morbidity and mortality. Liver transplantation (LT) offers a cure, but published data on outcomes after LT are limited. We assessed the...

see more →

Guidelines  1 results

Best practice guidelines on clinical management of acute attacks of porphyria and their...
https://doi.org/10.1177/0004563212474555
Annals of Clinical Biochemistry; Stein P, Badminton M et. al.

Apr 22nd, 2013 - The British and Irish Porphyria Network guidelines describe best practice in the clinical assessment, investigation and management of acute porphyria attacks and their complications, including severe attacks with neuropathy. Acute attacks of porph...

see more →

Drugs  67 results see all →

Clinicaltrials.gov  437 results

Panhematin - hemin powder, for solution-RECORDATI RARE DISEASES, INC.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9984267a-4d57-4444-9bb5-16bca7dea691

Apr 1st, 2021 - PANHEMATIN is a hemin for injection indicated for the amelioration of recurrent attacks of acute intermittent porphyria temporally related to the menstrual cycle in susceptible women, after initial carbohydrate therapy is known or suspected to be ...

Chlorpromazine hydrochloride - chlorpromazine hydrochloride tablet, film coated-Major Pharmaceuticals
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d58570a0-58b0-4662-b2ad-aa8d1463b4c1

Mar 28th, 2021 - For the management of manifestations of psychotic disorders. For the treatment of schizophrenia. To control nausea and vomiting. For relief of restlessness and apprehension before surgery. For acute intermittent porphyria. As an adjunct in the tre...

Chlorpromazine hydrochloride - chlorpromazine hydrochloride tablet, film coated-Glenmark Pharmaceuticals Inc., USA
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a6065ac5-a111-449b-b51b-8bc2907d1ddb

Mar 23rd, 2021 - For the management of manifestations of psychotic disorders. For the treatment of schizophrenia. To control nausea and vomiting. For relief of restlessness and apprehension before surgery. For acute intermittent porphyria. As an adjunct in the tre...

Chlorpromazine hydrochloride - chlorpromazine hydrochloride tablet, sugar coated-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3b8545ef-312d-4af6-a082-2497b84ff161

Feb 28th, 2021 - For the management of manifestations of psychotic disorders. For the treatment of schizophrenia. To control nausea and vomiting. For relief of restlessness and apprehension before surgery. For acute intermittent porphyria. As an adjunct in the tre...

Chlorpromazine hydrochloride - chlorpromazine hydrochloride tablet, film coated-REMEDYREPACK INC.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5bfe1700-9216-4ba3-bd9d-d0ea72735bdc

Feb 28th, 2021 - For the management of manifestations of psychotic disorders. For the treatment of schizophrenia. To control nausea and vomiting. For relief of restlessness and apprehension before surgery. For acute intermittent porphyria. As an adjunct in the tre...

see more →

News  9 results

Chronic blistering rash on hands
https://www.mdedge.com/familymedicine/article/211805/dermatology/chronic-blistering-rash-hands/page/0/2?channel=203
MDedge Family Medicine;

Nov 7th, 2019 - Pseudoporphyria has a similar presentation to PCT but with no abnormalities in porphyrin metabolism. Risk factors include UV radiation exposure; use of medications such as nonsteroidal anti-inflammatory drugs, diuretics, and retinoids; chronic ren.

VIDEO: Givosiran cuts acute intermittent porphyria attacks in pivotal trial
https://www.mdedge.com/internalmedicine/article/199737/hepatology/video-givosiran-cuts-acute-intermittent-porphyria-attacks/page/0/1?channel=39313

Apr 28th, 2019 - The study’s primary endpoint was the average annualized rate of porphyria attacks during 6 months of treatment, which was 3. 2 attacks in 46 patients evaluable for efficacy on givosiran treatment and 12.

Elusive Diagnosis of Acute Intermittent Porphyria in a Teenage Girl
https://www.medscape.com/viewarticle/889629

Dec 5th, 2017 - NEW YORK (Reuters Health) - Abdominal pain and hyponatremia in a 16-year-old girl with constipation and disordered eating confounded the diagnosis of a much less common condition, acute intermittent porphyria (AIP), according to a case report publ...

Case Report: Acute Intermittent Porphyria
https://www.mdedge.com/emergencymedicine/article/107206/hematology/case-report-acute-intermittent-porphyria/page/0/1

Mar 1st, 2016 - Treatment Treatment targets runaway heme precursor synthesis at its start and finish (Figure). Glucose-loading suppresses the initial enzyme, ALA synthase.

see more →